Researchers at the Dana-Farber Cancer Institute in Boston announced yesterday that they have identified a human antibody that powerfully blocks infection by the SARS virus. The discovery could lead to a new treatment for the potentially deadly disease that could be tested on humans in as little as a year. (Full Article: 395 Words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 Article
- $9.95 4 Articles
- $99.95 Unlimited
